Plain-English translation of NCT07381374 on ClinicalTrials.gov โ ยท Source last updated ยท Translation generated ยท How we translate trials
This study doesn't follow the usual testing phases โ it may be an observational study or a different type of research.
This trial is testing fecal microbiota transplantation (FMT) โ a treatment that transfers healthy gut bacteria from a donor into a child's digestive system โ to see if it can improve social interaction, communication, and other autism-related symptoms. Researchers know that children with autism often have different gut bacteria patterns than other children, and early studies suggest that balancing these bacteria might help with both behavior and digestion. This study will compare two different ways of delivering the treatment versus a placebo to figure out which method works best.
Many children with autism experience both social and communication challenges alongside digestive problems, and researchers have found that their gut bacteria are often out of balance. Early research suggests that this medication might help by restoring healthy bacteria and improving the connection between the gut and brain, but doctors need high-quality evidence to know if it really works and which delivery method is best.
You likely qualify ifโฆ
You likely don't qualify ifโฆ
If you join, you will be randomly assigned to receive either the real gut bacteria treatment or a placebo (inactive treatment). The treatment is delivered through one of two routes: either a thin tube passed through your nose to your small intestine, or through a colonoscopy procedure where a tube is placed in your colon. You will receive three infusions over about a week, then return for check-ups at 2, 6, 12, 24, and 48 weeks. At each visit, researchers will measure changes in your autism symptoms, digestive health, and gut bacteria using questionnaires and stool samples.
AI-generated summary from trial data ยท Jun 14, 2026 ยท Not medical advice
China